Profusa, Inc.

Profusa, Inc. is a medical technology company specializing in the design and development of tissue-integrated sensors and biosensors, with a primary focus on chronic disease management and personalized healthcare. Founded in 2009 and headquartered in Emeryville, California, Profusa’s core innovation lies in creating long-lasting, injectable biosensors that continuously monitor an individual’s body chemistry in real time. Its technology platform enables clinicians and patients to access trusted, actionable data for more informed health decisions. The company’s products address key challenges in diabetes management and have applications in the monitoring of critical limb ischemia and peripheral arterial disease. Profusa’s *Lumee™ Oxygen Platform*, already available in the European Union, reports tissue oxygen levels to help manage conditions involving compromised blood flow and healing, such as chronic wounds and reconstructive surgery. By integrating biosensors with advanced data analytics and smartphone connectivity, Profusa aims to empower users and healthcare professionals with deeper insights into health status and disease progression. As a publicly traded entity, Profusa represents a pioneering approach within the digital health and medical devices sectors, combining biotechnology and data science to advance continuous, patient-centric monitoring solutions.